Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
The analysis highlights History, Companies, Art and Science as prominent areas in the source structure around Ipsen.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Ipsen shows recurring relationship patterns in the source. For example, Ipsen → Additionally, As, Despite Russian, March, Russia, Ukraine Another extracted example is Ipsen → Fondation, France, In, It, The Fondation Ipsen. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment company rare medicine used patients beaufour group disease fondation henri drug united states diseases development france fda paris oncology
TTTA extracted 29 structured relationships around Ipsen. Examples in this analysis include Ipsen → Founded → 1929 and Ipsen → Founder → Henri Beaufour. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ipsen | Founded | 1929 | 1.00 | infobox |
| Ipsen | Founder | Henri Beaufour | 1.00 | infobox |
| Ipsen | Headquarters | Balard, Paris 15, France | 1.00 | infobox |
| Ipsen | Industry | Pharmaceutical | 1.00 | infobox |
| Ipsen | ISIN | FR0010259150 | 1.00 | infobox |
| Ipsen | Key people | Marc de Garidel (Non-executive Chairman) David Loew (Chief Executive Officer) | 1.00 | infobox |
| Ipsen | Net income | €347million(2024) | 1.00 | infobox |
| Ipsen | Number of employees | 5,300 | 1.00 | infobox |
| Ipsen | Operating income | €1.109 billion(2024) | 1.00 | infobox |
| Ipsen | Products | List of medicines | 1.00 | infobox |
| Ipsen | Revenue | €3.401 billion(2024) | 1.00 | infobox |
| Ipsen | Traded as | Euronext Paris: IPN CAC Mid 60 Component | 1.00 | infobox |
| Ipsen | Type | Public | 1.00 | infobox |
| Ipsen | Website | www.ipsen.com | 1.00 | infobox |
| Ipsen | is a | French biopharmaceutical company headquartered in Paris | 0.90 | text |
The concept neighborhoods around Ipsen bring nearby vocabulary together. In this analysis, examples include Fondation, Rare and Announced. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Ipsen, one of the stronger structural bridges in this analysis connects Ipsen with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Ipsen to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Companies, Art & Science, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Ipsen · EN edition · Analysis: TopicsToTalkAbout